Elite Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Elite Pharmaceuticals's balance sheet done over the years? Its assets were worth $83,653,536 last year, which is more than in the previous period. 31% of Elite Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $26,070,718, which means an increase by 118% compared compared to last year.
Debt to Assets
| 2015 | 25920279 | 60.65M | 233.99% |
|---|---|---|---|
| 2016 | 31878550 | 20.71M | 64.98% |
| 2017 | 34311142 | 8.64M | 25.2% |
| 2018 | 30882608 | 12.40M | 40.18% |
| 2019 | 24401934 | 13.00M | 53.3% |
| 2020 | 24956580 | 14.30M | 57.3% |
| 2021 | 26189492 | 10.03M | 38.33% |
| 2022 | 35148898 | 9.92M | 28.24% |
| 2023 | 40896018 | 11.93M | 29.19% |
| 2024 | 83653536 | 26.07M | 31.17% |
ELTP Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 7.10M | 7.83M | 8.53M | 3.19M | 1.13M | 2.27M | 7.17M | 10.59M | 11.51M | 7.46M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 19.45M | 3.09M | 3.05M | 3.49M | 4.10M | 1.32M | 675.87K | 934.05K | 1.53M | 1.44M |
Inventory | 12.93M | 9.55M | 6.74M | 5.01M | 4.14M | 4.51M | 4.89M | 6.41M | 3.29M | 3.03M |
Other current assets | 524.16K | 1.03M | 526.94K | 492.62K | 870.23K | 741.37K | 949.28K | 468.00K | 377.75K | 388.06K |
Total current assets | 40.01M | 21.51M | 18.86M | 12.19M | 10.25M | 8.85M | 13.70M | 18.41M | 16.71M | 12.33M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 14.61M | 10.43M | 6.98M | 6.86M | 7.59M | 8.44M | 8.99M | 9.03M | 8.11M | 6.40M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 6.34M | 6.34M | 6.63M | 6.63M | 6.63M | 6.63M | 7.71M | 6.41M | 6.41M | 6.38M |
Long term investments | 0 | 21.01K | 405.03K | 405.01K | 404.80K | 398.12K | 391.56K | 389.08K | 388.95K | 0 |
Other non-current assets | 527.07K | 412.43K | 91.73K | 496.75K | 480.33K | 467.50K | 81.93K | 439.92K | 253.11K | 806.01K |
Total non-current assets | 43.63M | 19.38M | 16.28M | 13.99M | 14.70M | 15.54M | 17.18M | 15.89M | 15.16M | 13.58M |
Total assets | 83.65M | 40.89M | 35.14M | 26.18M | 24.95M | 24.40M | 30.88M | 34.31M | 31.87M | 25.92M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 13.33K | 13.33K | 13.33K | 13.33K | 180K | 1.16M | 1.01M | 1.01M | 1.01M | 13.33K |
Short term debt | 5.02M | 325.76K | 556.78K | 598.90K | 2.06M | 653.85K | 654.66K | 486.97K | 1.28M | 1.05M |
Total current liabilities | 13.04M | 7.83M | 6.69M | 5.81M | 8.63M | 6.90M | 5.11M | 3.34M | 4.65M | 5.06M |
| Non-current liabilities: | ||||||||||
Long term debt | 6.71M | 3.56M | 2.22M | 1.77M | 1.96M | 3.32M | 3.33M | 2.16M | 2.36M | 2.62M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 6.29M | 521.71K | 975.61K | 37.62K | 35.44K | 46.40K | 41.14K | 875.23K | 27.89K | 17.95M |
Total non-current liabilities | 13.02M | 4.10M | 3.23M | 4.22M | 5.66M | 6.09M | 7.29M | 5.30M | 16.06M | 55.58M |
Total liabilities | 26.07M | 11.93M | 9.92M | 10.03M | 14.30M | 13.00M | 12.40M | 8.64M | 20.71M | 60.65M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |